Micell Technologies, Inc. has entered into an agreement with Hefei Life Science Technology Park Investment and Development Co., Ltd. (Hefei Life Science), for the clinical development, marketing and distribution of the MiStent Sirolimus Eluting Absorbable Polymer Coronary Stent System (MiStent...
All interested parties are welcome to join in the development of a proposed new ASTM International standard that will provide guidance on how to conduct axial, bending and torsional fatigue testing of stents. The proposed new standard, ASTM WK23330, Guide for in Vitro Axial, Bending and Torsional Durability Testing of Vascular Stents...
MIT’s new Institute for Medical Engineering and Science (IMES) is tackling some of the world’s biggest health challenges through an interdisciplinary approach that will seek new ways to diagnose and treat infectious, neurological and cardiovascular diseases.
Blood flow is routinely measured in the clinic, and laser speckle contrast imaging is one way of measuring these changes; however, this technique requires professional-grade imaging equipment, which limits its use. Now, using $90 worth of off-the-shelf commercial parts including a webcam and a laser pointer, researchers have duplicated the performance of expensive, scientific-grade LSCI instruments at a fraction of the cost.
Tracking blood flow in the laboratory is an important tool for studying ailments like migraines or strokes and designing new ways to address them. Blood flow is also routinely measured in the clinic, and laser speckle contrast imaging is one way of measuring these changes; however, this technique requires professional-grade imaging equipment, which limits its use.
Fluorescence imaging is the most widely used method for analyzing the molecular composition of biological specimens. Target molecules, when they are present, can be "tagged" with a fluorescent label and made visible. This highly sensitive technique, which is used in screening blood for cancer cells and studying biochemical reactions, is very good at detecting molecules present in extremely low concentrations.
Medical devices are increasingly dependent on software, evolving from the use of a simple two-transistor circuit for early artificial cardiac pacemakers to sophisticated modern systems supporting infusion pumps, electrocardiogram analysis, and image-guided surgery.
The Advanced Medical Technology Association (AdvaMed) today released a new study on pricing trends for implantable medical devices that shows average prices have declined significantly for major categories of implantable medical devices from 2007 through 2011.
TVA Medical's Minimally Invasive System for Hemodialysis Access Demonstrates Success in Clinical StudySeptember 26, 2013 1:51 pm | by PR Newswire | News | Comments
Preliminary data presented last week at the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) annual scientific meeting demonstrated that TVA Medical's FLEX System can create vascular access for hemodialysis patients without traditional open surgery.
A lawsuit headed to trial in New Mexico accuses a doctor, hospital and an international biomedical firm of teaming up to implant unneeded pacemakers and other devices in patients to boost profits. Tommy and Barbara Sowards are suing for damages after they say the doctor implanted an unneeded...
New research from Western University is leading to a better understanding of what happens during heart failure; knowledge that could lead to better therapeutics or a more accurate predictor of risk. The research--led by Robarts Research Institute scientists Robert Gros, Ph.D., and Marco Prado, Ph.D...
The research led by Robarts Research Institute scientists Robert Gros, PhD, and Marco Prado, PhD, along with graduate student Ashbeel Roy found the heart is regulated not only by nervous systems but also by heart cells sending messages to each other through the release of the neurotransmitter acetylcholine (ACh).
Researchers are using computer simulations to investigate how ultrasound and tiny bubbles injected into the bloodstream might break up blood clots, limiting the damage caused by a stroke in its first hours. Strokes are the most common cause of long-term disability in the United States and the third most common cause of death.
The Food and Drug Administration said Monday that it has approved broader use of an innovative artificial heart valve that can be implanted without major surgery, allowing surgeons to insert the implant through multiple pathways. The agency approved revised labeling for Edwards Lifesciences' Sapien heart valve...
FDA Approves Medtronic's Complete 'SE' Vascular Stent for Use in Superficial Femoral and Proximal Popliteal (Leg) ArteriesSeptember 24, 2013 11:42 am | by The Associated Press | News | Comments
Expanding its role in the treatment of peripheral artery disease in the United States, Medtronic, Inc. (NYSE: MDT) announced today that the U.S. Food and Drug Administration (FDA) has approved the Complete SE (self-expanding) vascular stent for use in the lower extremities -- specifically, the superficial femoral artery (SFA) and proximal popliteal artery (PPA), which carry blood through the upper legs.
The threat from a heart attack doesn't end with the event itself. Blockage of blood flow to the heart can cause irreversible cell death and scarring. With transplants scarce, half the people who live through a heart attack die within five years. Scientists are trying to address this problem by engineering cardiac tissue to patch up damaged areas.
In patients with an acute heart attack, remote ischemic conditioning – intermittent inflation of a blood pressure cuff to cut off blood flow to the arm during transportation to hospital for acute balloon dilatation – reduces subsequent cardiac symptoms and mortality after acute heart attack.
A team from the University of Texas at Arlington has used mathematical modeling to develop a computer simulation they hope will one day improve the treatment of dangerous reactions to medical implants such as stents, catheters and artificial joints.
Pacemakers, insulin pumps, defibrillators and other implantable medical devices often have wireless capabilities that allow emergency workers to monitor patients. But these devices have a potential downside: They can be hacked. Researchers at Rice University have come up with a secure way to dramatically cut the risk that an implanted medical device could be altered remotely without authorization.
Seven out of 9 hospitals and healthcare providers surveyed "strongly" agreed that medical device makers need to step up their cybersecurity and privacy practices, according to a study conducted by the Deloitte Center for Health Solutions.
In the field of medical technology, wireless devices are seeing some of the most broad-reaching growth. This is due mostly in part to the wide range of applications that wireless medicine encompasses. Mobi Health News reports that the top ten areas wireless medicine has directly benefited include: Alzheimer’s, asthma, breast cancer, COPD, depression, diabetes, heart failure, hypertension, obesity, and sleep disorders.
Hospitals in 2011 paid an average of 34% less for drug-eluting stents than they did in 2007, according to a new report. They also paid 27% less for bare metal stents and 26% less for both pacemakers and cardiac resynchronization therapy defibrillators.
Medtronic, Inc. has announced clinical trial results showing that heart failure patients treated with its exclusive AdaptivCRT feature experienced a nearly 50 percent reduction in atrial fibrillation (AF) risk. Pioneered by Medtronic, the AdaptivCRT technology is a feature on certain cardiac resynchronization therapy-defibrillators...
The medical device and diagnostics market is set to grow at 4.5 percent per year (CAGR) between 2012 and 2018, totalling $455 billion in 2018, according to the newly-released EvaluateMedTech World Preview 2013, Outlook to 2018: The Future of Medtech report from market intelligence firm Evaluate Ltd.
Vascular Dynamics, Inc. Initiates "First in Human" Clinical Study of Its MobiusHDTM Device for the Treatment of Drug Resistant HypertensionSeptember 23, 2013 8:31 am | by The Associated Press | News | Comments
Vascular Dynamics, Inc. (VDI) announced today the first patient has been treated with the MobiusHD device; a catheter-delivered implant designed for the treatment of drug resistant hypertension. Dr. Chandan Devireddy of Emory University School of Medicine treated the first patient in the FDA-approved CALM-FIM_US Study.